Ashwani Verma Analyst PerformanceAnalyst at UBS GroupAshwani Verma is a stock analyst at UBS Group in the medical sector, covering 13 publicly traded companies. Over the past year, Ashwani Verma has issued 24 stock ratings, including buy and hold recommendations. While full access to Ashwani Verma's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Ashwani Verma's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Ratings, Coverage, and Performance StatisticsAnalyst RatingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings24 Last 0 YearsBuy Recommendations75.00% 18 Buy RatingsCompanies Covered13 Unique Companies Ratings Distribution24RatingsDistribution of strong buy, buy, hold, and sell ratings by Ashwani Verma.RatingPercentageCount Strong Buy0.0%0 ratings Buy75.0%18 ratings Hold25.0%6 ratings Sell0.0%0 ratingsOut of 24 total stock ratings issued by Ashwani Verma at UBS Group, the majority (75.0%) have been Buy recommendations, followed by 25.0% Hold.Best & Worst CallsThis analyst does not have any ratings with enough history to determine best and worst calls.Exchange CoverageExchangePercentageCountNASDAQ92.3% of companies on NASDAQ12 companiesNYSE7.7% of companies on NYSE1 companyAshwani Verma, an analyst at UBS Group, currently covers 13 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical13 companies100.0%Ashwani Verma of UBS Group specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE9 companies69.2%MED - DRUGS3 companies23.1%MED - GENERIC DRG1 company7.7% Ashwani Verma's Ratings History at UBS Group Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export to Excel CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsACADACADIA Pharmaceuticals9/9/2025Boost Price Target$25.47$39.00Buy$0.0000.00% ROIUTHRUnited Therapeutics9/4/2025Boost Price Target$391.45$560.00Buy$0.0000.00% ROIAVDLAvadel Pharmaceuticals8/21/2025Boost Price Target$14.54$20.00Buy$0.0000.00% ROIUTHRUnited Therapeutics8/13/2025Boost Price Target$301.39$415.00Buy$0.0000.00% ROIACADACADIA Pharmaceuticals8/8/2025Boost Price Target$24.63$36.00Buy$0.0000.00% ROIEXELExelixis7/30/2025Set Price Target$37.60$38.00Neutral$0.0000.00% ROIIMVTImmunovant7/28/2025Boost Price Target$16.76$18.00Neutral$0.0000.00% ROIEXELExelixis7/11/2025Set Price Target$44.86$43.00Neutral$0.0000.00% ROINBIXNeurocrine Biosciences7/9/2025Boost Price Target$130.90$174.00Buy$0.0000.00% ROILEGNLegend Biotech7/2/2025Set Price Target$35.92$54.00Buy$0.0000.00% ROIUTHRUnited Therapeutics6/30/2025Lower Price Target$287.25$385.00Buy$0.0000.00% ROITEVATeva Pharmaceutical Industries6/26/2025Lower Price Target$17.00$23.00Buy$0.0000.00% ROINBIXNeurocrine Biosciences5/6/2025Boost Price Target$125.03$152.00Buy$0.0000.00% ROICYTKCytokinetics5/2/2025Lower Price Target$37.35$41.00Neutral$0.0000.00% ROIHRMYHarmony Biosciences4/28/2025Lower Price Target$29.36$48.00Buy$0.0000.00% ROIACADACADIA Pharmaceuticals4/28/2025Lower Price Target$14.66$22.00Buy$0.0000.00% ROICHRSCoherus Oncology4/24/2025Reiterated Rating$1.07$1.05Neutral$0.0000.00% ROINBIXNeurocrine Biosciences4/4/2025Lower Price Target$95.14$137.00Buy$0.0000.00% ROIJAZZJazz Pharmaceuticals3/7/2025Upgrade$136.45$179.00Buy$0.0000.00% ROIALKSAlkermes3/4/2025Upgrade$34.11$38.00Neutral$0.0000.00% ROINBIXNeurocrine Biosciences1/30/2025Boost Price Target$153.29$176.00Buy$0.0000.00% ROITEVATeva Pharmaceutical Industries1/30/2025Lower Price Target$17.88$27.00Buy$0.0000.00% ROITEVATeva Pharmaceutical Industries1/23/2025Boost Price Target$22.00$30.00Buy$0.0000.00% ROIAVDLAvadel Pharmaceuticals1/13/2025Lower Price Target$7.83$14.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
